Table 2.
Crosstab comparison of the distribution of patients according to the 2009 and the 2018 FIGO staging systems.
| FIGO Staging Systems |
Pathological FIGO Stage 2018 n. (%) | Total | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| IB1 | IB2 | IB3 | IIA1 | IIA2 | IIB | IIIC1 | IIIC2 | |||
| Pathological FIGO stage 2009 n. (%) |
IB1 | 209 (50.0) |
148 (35.4) |
0 | 0 | 0 | 0 |
54
(12.9) |
7
(1.7) |
418 (100) |
| IB2 | 0 | 0 | 22 (73.3) |
0 | 0 | 0 |
6
(20.0) |
2
(6.7) |
30 (100) |
|
| IIA1 | 0 | 0 | 0 | 30 (71.4) |
0 | 0 |
11
(26.2) |
1
(2.4) |
42 (100) |
|
| IIA2 | 0 | 0 | 0 | 0 | 8 (88.9) |
0 |
1
(11.1) |
0 |
9 (100) |
|
| IIB | 0 | 0 | 0 | 0 | 0 | 22 (52.4) |
17
(40.5) |
3
(7.1) |
42 (100) |
|
| Total | 209 (38.6) |
148 (27.4) |
22 (4.1) |
30 (5.5) |
8 (1.5) |
22 (4.1) |
89
(16.5) |
13
(2.4) |
541 (100) |
|
Bold: it underline patients taken into account in further analyses.